NeuBase Therapeutics Inc Myotonic Dystrophy Type 1 Data Webinar Transcript
Good morning, and thank you for joining us for today's call to discuss NeuBase's preclinical data for the company's myotonic dystrophy program. (Conference Instructions) As a reminder, this webinar is being recorded and a replay will be made available on the NeuBase website following the event.
I would now like to turn the call over to your host, Dietrich Stephan, Ph.D., Chief Executive Officer at NeuBase. Please go ahead, Dietrich.
Thanks, Dan. Good morning, my name is Dietrich Stephan, the Chairman and CEO of NeuBase Therapeutics. Today, I'm proud to present a data package that is a culmination of the hard work of a simply amazing team here at NeuBase. I'm happy to represent this team's work today.
Joining me on the line is a senior management team of NeuBase: Sam Backenroth, our CFO; Dr. Bill Mann, our COO; and Dr. Curt Bradshaw, our CSO and newest team member. All of us will be available to answer questions after the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
